The University of Florida Health Cancer Center has expanded its research programs to strengthen the impact of cancer research and meet the needs of an expanding membership. The expansion will make it easier and faster for investigators to directly apply their discoveries to clinical care, for the ultimate benefit of patients and community members.
The expansion is part of the center’s continued development as a National Cancer Institute-designated cancer center. The new programs will deepen the center’s collaboration with colleagues at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, leveraging leading-edge technology such as robot-assisted drug discovery to complement pharmacogenomics research at UF. At the same time, it will bring together experts who are conducting research across the immunotherapy spectrum, from the brain to the gut microbiome.
“We are providing more opportunities for our members to collaborate across departments and across campuses, in keeping with our ‘all hands on deck’ approach to solving the problem of cancer,” said Thomas George, M.D., FACP, deputy director of the Cancer Center. “Our goal is to spur more translation of our research findings directly to clinical trials, for the ultimate benefit of our patients and communities.”
More Information: Here
